Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...